Gastroesophageal reflux disease: Short-term management strategies

Consultant

Volumn 37, Issue 5, 1997, Pages 1329-1348

  Johnson, David A ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTACID AGENT; ANTIARRHYTHMIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; NIZATIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; POTASSIUM DERIVATIVE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; QUINIDINE; RANITIDINE; SEDATIVE AGENT;

BODY POSTURE; COMBINATION CHEMOTHERAPY; DIET RESTRICTION; DISEASE SEVERITY; DRUG INDICATION; DRUG MEGADOSE; ESOPHAGITIS; ESOPHAGUS MOTILITY; ESOPHAGUS PH; EXTRAPYRAMIDAL SYMPTOM; FOOD COMPOSITION; GASTROESOPHAGEAL REFLUX; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SMOKING CESSATION; WEIGHT REDUCTION;

EID: 0031296033     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Dimenas E. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases. Scand J Gastroenterol. 1993;28:18-21.
2. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology. 1995;109:601-610.
3. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994;343:811-816.
4. Fennerty MB, Castell D, Fendrick M, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment suggested disease management guidelines. Arch Intern Med. 1996;156:477-484.
5. Johnson JA. Medical therapy for gastroesophageal reflux disease. Am J Med. 1992;92(suppl 5A):88S-95S.
6. 2 receptor antagonists in the management of gastroesophageal reflux disease. Aliment Pharmacol Ther. 1995;9:9-14.
7. 2RA) resistant reflux esophagitis. Gastroenterology. 1991;100:A29.
8. Tytgat GNJ, Koelz H-R, Vosmaer GDC, the Sucralfate Investigational Working Team. Sucralfate maintenance therapy in reflux esophagitis. Am J Gastroenterol. 1995;90:1233-1237.
9. Ramirez B, Richter JE. Review article: promotility drugs and the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1993;7:5-20.
10. Geldof H, Hazelhoff B, Often MH. Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine. Aliment Pharmacol Ther. 1993;7:409-415.
11. Robinson M, Deckator DL, Maton PN, et al. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis. Aliment Pharmacol Ther. 1993;7:67-73.
12. Mundo F, Felix R, Aguilar J, et al. Omeprazole vs ranitidine plus cisapride in the treatment of reflux oesophagitis: comparative endoscopic study. Am J Gastroenterol. 1992;87:1254.